Table 2.

Clinical response to colchicine in FMF patients

Subgroups			Response rate		p
Sure	vs	Probable	91/93 (97.8 %)	74/80 (92.5 %)	0.095
(0.82 ± 0.40)*		(0.84 ± 0.54)*
MEFV mutations (+)	vs	MEFV mutations (–)	154/162 (95.1 %)	11/11 (100 %)	0.585
M694I (+)	vs	M694I (–)	36/37 (97.3 %)	129/136 (94.9 %)	0.459
E148Q (+)	vs	E148Q (–)	109/115 (94.8 %)	56/58 (96.6 %)	0.461
Rheumatic diseases (+)	vs	Rheumatic diseases (–)	23/23 (100 %)	142/150 (94.7 %)	0.311

*Mean dose of colchicine, mg/day. FMF familial Mediterranean fever